4Shapiro DA, Rencock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsycho phamacology ,2003,28:1400-1411.
5Potkin SG, Saha AR, Kujawa MJ, et al. Ari piprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry,2003,60: 681-690.
6Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term placebo-controlled trials. Schizophr Res,2003,61:123-136.
1Jordan S, Kopriviea V, Chen R, et al, The antipsyehotic aripiprazole is a potent, partial agonist at the human 5-HT1A reeeptor[J].Eur J Pharmacol, 2002, (441 ) : 137 - 140.
2Hirose T, Uwahodo Y, Yamada S, et al. Efficacy and favorable side-effect profile of aripiprazole determined in rat with apomorphine-induced stereotype, catalepsy, and ptosis induction [ J ]. Int J Neuropsychopharm, 2000,3 (Suppl) :S131 - S136.
3Burris KD, Molski TF, Ryan E, et al. Aripiprazole is a high affinity partial agonist at human D2 doparnine receptors[J]. Int J Neuropsychopharm ,2000,3(Suppl) :S129 - S130.
4Jordan S, Kopriviea V, Chen R, et al. The antipsyehotie aripiprazole is a potent partial agonist at the human 5-HTIA receptors[J]. Eur Neuropsychopharm, 2001,11 (Suppl 3) :S268 - S273.
5Petrie J L, Saha AR, McEvoy JP, Aripiprasole, a new antipsychotic: phase Ⅱ clinical trial result [J ]. Eur Neuropsychopharm,1997,7(Suppl 2) :S227 - S230.
6Daniel DG,Saha AR, Ingenito G, et al. Aripiprazole,a novel antipsyehotie:overview of a phase Ⅱ study result[J]. Int J Neuropsychopharm, 2000,3 (Suppl 1 ) : S157 - S160.
7Kane J, Ingenito G, All M. Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo [J ]. Int J Neuropsychopharm, 2000,3 (Suppl 1 ) : S124 - S128.
8Carson WH, Kane J, Ali M, et al. Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo[J]. Int J Neuropsychopharm, 2000,10 (Suppl 3) : S309 - S312.
9Saha AR,Carson WH,Ali MW,et al. Efficacy and safety of aripiprazole and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder[J]. WJ Biol Psychiat ,2001,2(Suppl1) : S305 - S308.
10Kern RS,Cornblatt B,Carson WH, et al. An open-label comparison of the neuroeognitive effects of aripiprazole vs olanzapine in patients with stable psyehosis[J]. Schizophr Res, 2001,49(1 -2) (Suppl):S234 - S237.
